Resultados de la búsqueda 401-410 of 5870 for 정보이용료현금ᐲ 【캬툑R2222】【달봉티켓】 boston정보이용료현금さ콘텐츠이용료현금last 구글결제현금화⒬소액결제정책ⓞ소액결제대행사la핸드폰결제현금화descent
Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these samples to ...
Obtén más información más sobre la experiencia y los servicios, incluidos los de medicina para viajes, que se ofrecen en Mayo Clinic para las personas con ...
Accessed Aug. 30, 2022. Lee CI, et al. Risk-based breast cancer screening: Implications of breast density. The Medical Clinics of North America. 2017; doi: ...
Rochester, Minn., Scottsdale/Phoenix, Ariz. The standard treatment for locally advanced rectal cancer involves chemotherapy and radiation, known as 5FUCMT, (the ...
This part will collect information on the leukemia, as well as the effects of the initial treatment, in order to classify patients into post-consolidation ...
Niraparib will be combined with trastuzumab, a HER2-targeted agent, to evaluate the safety and tolerability in patients with metastatic HER2 positive breast ...
The purpose of ths study is to find out more about the side effects of two new drug combinations for lymphoma, TTI-621 and pembrolizumab and TTI-622 and ...
Rochester, Minn. This phase II trial studies the effect of pembrolizumab, dabrafenib, and trametinib before surgery in treating patients with BRAF V600E-mutated ...
This phase II trial studies the effect of pembrolizumab, dabrafenib, and trametinib before surgery in treating patients with BRAF V600E-mutated anaplastic ...
The purpose of this study is to evaluate the safety and feasibility of the spinal array in treatment of patients with leptomeningeal metastases within the ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?